We have developed a multidisciplinary global consortium of researchers who can provide independent high-quality evidence regarding the scale of illicit drug use, harms, access to services at country, regional and global levels, and build capacity for better data in these areas.
This project attempts to understand the global epidemiology of infectious disease among prisoners in all countries.
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
Changes to the status of cannabis, ranging from legalisation through to tougher enforcement of prohibition are frequently posed. To date, the debate has centred on arguments associated with liberty and harm, but not on economic analyses.
With NSW having the largest GLBT community in Australia, it is important that responses to the problems faced by these populations (including a higher risk of drug use and mental health problems) are informed by research evidence.
Tobacco smoking is a leading cause of preventable disease and death. Smoking rates are higher among disadvantaged Australians and facilitating smoking cessation in this group is a national health priority.
In this study, we will undertake detailed analyses of the largest cross-national epidemiologic study of mental and substance use disorders ever conducted. The WHO World Mental Health Survey (WMHS) initiative is a massive, unique endeavour.
The main aim of this cross-cultural comparative study of marijuana markets in Australia, United States (Florida) and the Czech Republic is to improve knowledge of what impacts different legal regimes have on marijuana markets.
People who use heroin commonly spend time in prison. Contact with treatment services after release from prison is important for reducing the risk that released heroin users will return to regular drug use.